Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2007 2
2008 1
2009 1
2010 1
2011 1
2012 3
2013 2
2014 1
2015 3
2016 4
2017 6
2018 7
2019 7
2020 19
2021 10
2022 4
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative and palliative systemic treatments for biliary tract cancer.
Taghizadeh H, Dong Y, Gruenberger T, Prager GW. Taghizadeh H, et al. Among authors: prager gw. Ther Adv Med Oncol. 2024 Mar 30;16:17588359241230756. doi: 10.1177/17588359241230756. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38559612 Free PMC article. Review.
A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.
Tabernero J, Yoshino T, Stintzing S, de Gramont A, Gibbs P, Jonker DJ, Nygren P, Papadimitriou C, Prager GW, Tell R, Lenz HJ. Tabernero J, et al. Among authors: prager gw. Cancer Res Commun. 2024 Jan 4;4(1):28-37. doi: 10.1158/2767-9764.CRC-23-0361. Cancer Res Commun. 2024. PMID: 38059497 Free PMC article. Clinical Trial.
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe.
Taieb J, Seufferlein T, Reni M, Palmer DH, Bridgewater JA, Cubillo A, Prager GW, Vermeire A, Hédouin-Biville F, Teng Z, Macarulla T. Taieb J, et al. Among authors: prager gw. BMC Cancer. 2023 Sep 18;23(1):877. doi: 10.1186/s12885-023-11377-1. BMC Cancer. 2023. PMID: 37723453 Free PMC article.
Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
Tabernero J, Fakih M, Prager GW. Tabernero J, et al. Among authors: prager gw. N Engl J Med. 2023 Jul 13;389(2):190-191. doi: 10.1056/NEJMc2306486. N Engl J Med. 2023. PMID: 37437153 No abstract available.
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
Stintzing S, Heinrich K, Tougeron D, Modest DP, Schwaner I, Eucker J, Pihusch R, Stauch M, Kaiser F, Kahl C, Karthaus M, Müller C, Burkart C, Reinacher-Schick A, Kasper-Virchow S, Fischer von Weikersthal L, Krammer-Steiner B, Prager GW, Taieb J, Heinemann V. Stintzing S, et al. J Clin Oncol. 2023 Sep 1;41(25):4143-4153. doi: 10.1200/JCO.22.01420. Epub 2023 Jun 23. J Clin Oncol. 2023. PMID: 37352476 Clinical Trial.
84 results